Results 131 to 140 of about 6,286 (187)

Unveiling the Role of CCL3: A Driver of CIPN in Colon Cancer Patients? [PDF]

Biomedicines
Luzac I, Regalado CR, Balogh M.
europepmc   +1 more source

Astrocytic CCL5 orchestrates CCR5-positive neuronal necroptosis in subarachnoid hemorrhage. [PDF]

J Neuroinflammation
Chen P, Jiang YH, Xue SQ, Wang Y, Lin WL, Shi MY, Li SJ, Sun WW, Zhao JX, Kang DZ, Ye ZC, Lin QS.   +11 more
europepmc   +1 more source

Host Cell Virus Interactions: Molecular Mechanisms, Immune Modulation, Viral Pathogenesis, and Emerging Therapeutic Targets. [PDF]

Viruses
Alanazi A, Ibrahim MN, El Azab EF, Elithy MA.   +3 more
europepmc   +1 more source

HIV envelope pseudotyped virus- an indispensable tool in HIV research. [PDF]

Virus Res
Vivekanandan S, Sonawane A, Hanna LE.
europepmc   +1 more source

Structural insights into GPCR signaling activated by peptide ligands: from molecular mechanism to therapeutic application. [PDF]

Exp Mol Med
Kim J, Kim J, Choi C, Bae J, Choi HJ.
europepmc   +1 more source

CCR5 expression and conformational stability as potential cooperative modulators of immune phenotypes and therapy response in breast cancer. [PDF]

Discov Oncol
Hu E, Qiu P, Dekker A, Wee L, Quan C, Zhang D, Liang W, Xie N.   +7 more
europepmc   +1 more source

The Role of Mesenchymal Stem Cells in Drug Resistance in Lung Neoplasms. [PDF]

J Cancer Prev
Kang D, Yeon E, Kim S, Han E, Kang T, Song H, Kim J.   +6 more
europepmc   +1 more source

MAIT cell responses to S. aureus and sensitivity to HlgAB are modulated by activation and tissue-dependent virulence effects

Raineri EJM, Boulouis C, Mouchtaridi E, Nilsén V, Cai C, Kammann T, Tabusse J, Sekine T, Wild N, Constantz C, White E, Müller TR, Marchalot A, Ferreira S, Kaushal J, Mily A, Franklin M, Bonaiti E, Eichhorn M, Bassett J, Stamper C, Mak JYW, Fairlie DP, Tibbitt C, Norrby-Teglund A, Marquardt N, Mjösberg J, Jorns C, Driving J, Leeansyah E, Buggert M, Sandberg JK.   +31 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CCR5 receptor antagonists: Discovery and SAR study of guanylhydrazone derivatives

Bioorganic and Medicinal Chemistry Letters, 2007
High throughput screening (HTS) led to the identification of the guanylhydrazone of 2-(4-chlorobenzyloxy)-5-bromobenzaldehyde as a CCR5 receptor antagonist. Initial modifications of the guanylhydrazone series indicated that substitution of the benzyl group at the para-position was well tolerated.
Gary B Phillips
exaly   +3 more sources